Belumosudil for the treatment of chronic graft-versus-host disease: a single center real-world experience

Related articles

1. Ruxolitinib treatment outcomes in acute graft-versus-host disease (aGvHD) in a real-world setting in Finland

   This article has 9 authors:

   1. Eeva Martelin
   2. Arttu Kuikka
   3. Hanna Rajala
   4. Tuomas Ruohonen
   5. Hannu Mönkkönen
   6. Johanna Vikkula
   7. Kristiina Uusi-Rauva
   8. Urpu Salmenniemi
   9. Maija Itälä-Remes

2. Precision dosing of intravenous busulfan in infants patients undergoing bone marrow transplantation in China

   This article has 20 authors:

   1. Duan-fang Shao
   2. Shun-qiao Feng
   3. Zhao-xia Zhang
   4. Tao Hu
   5. Meng-ze Hu
   6. Wei Fan
   7. Li-tian Xuan
   8. Di-xiao Zhong
   9. Rui-hong Tang
   10. Ze-liang Song
   11. Meng-na Zhai
   12. Dan-qing Luo
   13. Jing Cao
   14. Yu-yang Wang
   15. Mei Yue
   16. Li-xiao Shi
   17. Jun-hui Li
   18. Rong Liu
   19. Lei Zhang
   20. Juan-juan Li

3. Activity of CAR-T Cells and Bispecific Antibodies in Multiple Myeloma with Extramedullary Involvement

   This article has 25 authors:

   1. Leo Rasche
   2. Maximilian Steinhardt
   3. Christoph Schaefers
   4. Lisa Leypoldt
   5. Igor-Wolfgang Blau
   6. Marie Harzer
   7. Xiang Zhou
   8. Christine Riedhammer
   9. Abdulaziz Kamili
   10. Ricardo Kosch
   11. Laura Topp
   12. Isabel Molwitz
   13. Nils-Ole Gross-Fengels
   14. Yasmin Fede Melzer
   15. Jule Artzenroth
   16. Maximilian Al-Bazaz
   17. Winfried Alsdorf
   18. Max Topp
   19. Johannes Duell
   20. Julia Mersi
   21. Johannes Waldschmidt
   22. Carsten Bokemeyer
   23. Hermann Einsele
   24. Martin Kortüm
   25. Katja Weisel